MBXC-4522
MBXC-4522 is an RVFV-EndoN inhibitor with an IC50 of 2.8 μM. MBXC-4522 exhibits antiviral activity. MBXC-4522 binds to and stabilizes the RVFV endonuclease through a metal-independent mechanism, inhibiting its activity and thereby blocking the viral "cap-snatching" mechanism. MBXC-4522 can be used for research on Rift Valley fever virus infection.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1340680-75-2
- Fòrmula: C23H29N5O2S
- Peso molecular:439.57
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | CC50 |
30.1 μM
|
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| HepG2 | CC50 |
73.8 μM
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| Vero | CC50 |
45.0 μM
|
Cytotoxicity against african green monkey Vero cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against african green monkey Vero cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| BV-2 | CC50 |
43.0 μM
|
Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
In Vitro
MBXC-4522 (5-50 μM; 16 h) significantly inhibits RVFV-MP12GFP attenuated virus infection in BV2 cells[1].
MBXC-4522 inhibits purified RVFV-EndoN endonuclease activity in a dose-dependent manner, with an IC50 of 2.8 μM[1].
MBXC-4522 (5-50 μM; 18 h) inhibits RVFV (ZH501), SFTSV, and HRTV viral antigen expression, plaque formation, and reduces viral RNA levels in Vero E6 cells[1].
MBXC-4522 (0.1-100 μM; 72 h) exhibits dose-dependent cytotoxicity with low cytotoxicity in HEK293 (CC50 = 30.1 µM), HepG2 (CC50 = 73.8 µM), Vero (CC50 = 45.0 µM), and BV2 (CC50 = 43.0 µM) cell lines[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293, HepG2, Vero6, BV2
-
Concentration:0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM
-
Incubation Time:72 h
-
Result:Exhibited CC50 values of 30.1 μM in HEK293 cells, 73.8 μM in HepG2 cells, 45.0 μM in Vero6 cells, and 43.0 μM in BV2 cells.
Chemical Information
-
No. CAS 1340680-75-2
-
Peso molecular 439.57
-
Fòrmula C23H29N5O2S
-
SMILES
O=S(C1=C(C)C=CC=C1)(N2CC3(NC4=CC=CN=C4N=C3NC5CCCC5)CCC2)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)